practice are regimens such as cisplatin or carboplatin combined with paclitaxel, vinorelbine, gemcitabine, docetaxel or … analyses have been conducted on paclitaxel in NSCLC and most have focused on its use in combination with cisplatin. In terms of … clinical efficacy, paclitaxel-cisplatin combinations achieved significantly higher response rates than teniposide plus …

trial in which the reference regimen cisplatin-paclitaxel was compared with two experimental regimens: cisplatin …-gemcitabine and gemcitabine-paclitaxel. Materials and methods: Unit costs were applied to resource use data collected prospectively on … same time improving survival. Compared with cisplatin-paclitaxel, the gemcitabine-paclitaxel regimen engendered a …

Paclitaxel belongs to the group of antitumour agents called the taxanes. Its efficacy in advanced ovarian cancer has … year. Paclitaxel plus carboplatin has similar efficacy to paclitaxel plus cisplatin. There is now consensus that paclitaxel … particular combination employed may vary between institutions and geographical regions, although paclitaxel plus carboplatin is …